Invention Grant
- Patent Title: Topical composition
-
Application No.: US16982281Application Date: 2019-03-18
-
Publication No.: US11696919B2Publication Date: 2023-07-11
- Inventor: Nigel Crutchley , Michelle Georgiou , Stephen Lenon , Morten Praestegaard
- Applicant: MC2 Therapeutics Limited
- Applicant Address: GB Guildford
- Assignee: MC2 Therapeutics Limited
- Current Assignee: MC2 Therapeutics Limited
- Current Assignee Address: GB Guildford
- Agency: Merchant & Gould P.C.
- Priority: EP 162664 2018.03.19
- International Application: PCT/EP2019/056735 2019.03.18
- International Announcement: WO2019/179958A 2019.09.26
- Date entered country: 2020-09-18
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; A61K9/06 ; A61K47/10 ; A61K47/12 ; A61P17/10 ; A61P17/00 ; A61P17/04 ; A61P31/04 ; A61K31/573 ; A61K9/00 ; A61K31/047 ; A61K31/085 ; A61K31/355 ; A61K47/44
Abstract:
The present invention relates to a composition for topical application comprising a polyaphron dispersion, the polyaphron dispersion comprising a continuous aqueous phase and at least one discontinuous oil phase,
wherein the polyaphron dispersion comprises calcipotriol, betamethasone dipropionate, alpha-tocopherol and butylated hydroxyanisole, and
wherein the composition has a pH of 7.75±0.5.
wherein the polyaphron dispersion comprises calcipotriol, betamethasone dipropionate, alpha-tocopherol and butylated hydroxyanisole, and
wherein the composition has a pH of 7.75±0.5.
Public/Granted literature
- US11638711B2 Topical composition Public/Granted day:2023-05-02
Information query
IPC分类:
